Trial Profile
Effect of nebivolol on all cause mortality and cardiovascular hospital admissions in older patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 11 Jan 2022
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms SENIORS
- 05 Nov 2010 New trial record.